Metastatic Male Breast Cancer With Increased Uptake on 18F-Fluciclovine PET/CT Scan

被引：11

作者：

Gill, Harkanwar S. ^{[1
]}

Tade, Funmilayo ^{[2
]}

Greenwald, David Theodore ^{[3
]}

Yonover, Paul M. ^{[3
]}

Savir-Baruch, Bital ^{[1
]}

机构：

[1] Loyola Univ Med Ctr, Div Nucl Med, Dept Radiol, Maywood, IL 60153 USA

[2] Emory Univ, Dept Radiol & Imaging Sci, Div Nucl Med & Mol Imaging, Atlanta, GA 30322 USA

[3] Univ Illinois, Dept Urol, Chicago, IL USA

来源：

CLINICAL NUCLEAR MEDICINE | 2018年 / 43卷 / 01期

关键词：

F-18; Fluciclovine; Axumin; breast cancer; FACBC; male; PET; CT; ACID;

D O I：

10.1097/RLU.0000000000001893

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Prostate imaging with F-18-labeled 1-amino-3-fluorocyclobutane-1-carboxylic acid (FACBC, F-18-fluciclovine) PET/CT scan (Axumin) was recently approved by the US Food and Drug Administration for men with suspected prostate cancer recurrence based on elevated blood prostate-specific antigen levels following prior treatment. We present a rare case of a 77-year-old man with suspected recurrent prostate cancer with an incidental finding of advanced-stage breast cancer showing different degrees of F-18-fluciclovine uptake.

引用

页码：23 / 24

页数：2

共 50 条

[31] Is There Any Role for 18F-Fluciclovine PET/CT in the Presence of Undetectable PSA in Prostate Cancer Patients After Definitive Treatment?
Teyateeti, Ajalaya
Teyateeti, Achiraya
Macapinlac, Homer A.
Lu, Yang
CLINICAL NUCLEAR MEDICINE, 2020, 45 (09) : 672 - 678
[32] Review of 18F-Fluciclovine PET for Detection of Recurrent Prostate Cancer
Gusman, Mariya
Aminsharifi, Jamie A.
Peacock, Justin G.
Anderson, Shane B.
Clemenshaw, Michael N.
Banks, Kevin P.
RADIOGRAPHICS, 2019, 39 (03) : 822 - 841
[33] Imaging Characteristics of Coexisting Metastatic Papillary Thyroid Cancer and Prostate Cancer on 18F-Fluciclovine and 68Ga-PSMA-11 PET/CT
Lu, Yang
CLINICAL NUCLEAR MEDICINE, 2022, 47 (09) : 820 - 821
[34] The "Ultimate Triple PET" 68Ga-DOTATATE, 18F-FDG, and 18F-Fluciclovine PET/CT Findings in a Single Patient With Metastatic Abdominal Carcinoid and Prostate Cancer
McClenathan, Matthew
Peacock, Justin G.
CLINICAL NUCLEAR MEDICINE, 2022, 47 (02) : E161 - E164
[35] Detection of Additional Primary Neoplasms on 18F-Fluciclovine PET/CT in Patients with Primary Prostate Cancer
Parihar, Ashwin Singh
Schmidt, Lisa R.
Dehdashti, Farrokh
Wahl, Richard L.
JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (05) : 713 - 719
[36] Reader Training for the Restaging of Biochemically Recurrent Prostate Cancer Using 18F-Fluciclovine PET/CT
Miller, Matthew P.
Kostakoglu, Lale
Pryma, Daniel
Yu, Jian Qin
Chau, Albert
Perlman, Eric
Clarke, Bonnie
Rosen, Donald
Ward, Penelope
JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (10) : 1596 - 1602
[37] Diagnostic accuracy of 18F-fluciclovine PET/CT in primary lymph node staging of prostate cancer
Hoekstra, Robert J.
Beulens, Alexander
Vrijhof, Eric H. J. E. J.
Wyndaele, Dirk N. J.
Roef, Mark
Brouwer, Lenneke J. M.
Somford, Diederik M.
Sedelaar, Michiel
van Basten, Jean-Paul A.
NUCLEAR MEDICINE COMMUNICATIONS, 2021, 42 (05) : 476 - 481
[38] Multifocal Meningiomas Mimicking Dural-Based Intracranial Metastases at 18F-Fluciclovine PET/CT
Manganaro, Mark S.
Millet, John D.
Manganaro, Matthew S.
CLINICAL NUCLEAR MEDICINE, 2019, 44 (07) : 594 - 595
[39] Lesion segmentation on 18F-fluciclovine PET/CT images using deep learning
Wang, Tonghe
Lei, Yang
Schreibmann, Eduard
Roper, Justin
Liu, Tian
Schuster, David M.
Jani, Ashesh B.
Yang, Xiaofeng
FRONTIERS IN ONCOLOGY, 2023, 13
[40] Papillary Urothelial Carcinoma of Urinary Bladder Identified on 18F-Fluciclovine PET/CT
Meka, Vamsi Mohan
Wankhar, Baphiralyne
Ojili, Vijayanadh
Batchala, Prem P.
CLINICAL NUCLEAR MEDICINE, 2021, 46 (08) : E438 - E439

← 1 2 3 4 5 →